Intravitreal triamcinolone for cancer-associated retinopathy refractory to systemic therapy

PURPOSE: The purpose of this study is to report the use of intravitreal triamcinolone for treatment of cancer-associated retinopathy (CAR) refractory to systemic therapy. METHODS: This was a retrospective chart review study. RESULTS: A 67-year-old man presented with cancer-associated retinopathy wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Huynh, Nancy, Shildkrot, Yevgeniy, Lobo, Ann-Marie, Sobrin, Lucia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer-Verlag 2012
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3438305/
https://www.ncbi.nlm.nih.gov/pubmed/22415770
http://dx.doi.org/10.1007/s12348-012-0067-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3438305/
https://www.ncbi.nlm.nih.gov/pubmed/22415770
http://dx.doi.org/10.1007/s12348-012-0067-9

Ejemplares similares